Dementia and Alzheimer’s Guide
A guide to distinguishing ordinary aging from cognitive change that affects daily function, understanding assessment, and addressing modifiable risks.
Contents
Normal aging or dementia?
Occasionally taking longer to recall a name does not by itself mean dementia. Dementia is a syndrome in which changes in memory, language, attention, navigation, judgment, or behavior interfere with everyday independence; it is not an inevitable part of aging. Alzheimer’s disease is a common cause, while vascular disease, Lewy body dementia, frontotemporal disorders, or mixed causes may be involved. Depression, sleep disorders, thyroid disease, medicines, hearing loss, and vitamin deficiency can also affect cognition.
| May occur with ordinary aging | Change that deserves assessment |
|---|---|
| Forgetting an appointment, then remembering | Repeatedly losing newly learned information |
| Occasionally taking time to find a word | Frequently losing the thread of speech |
| Sometimes searching for a misplaced item | Putting items in unusual places and being unable to retrace steps |
| Brief confusion in a new place | Getting lost in a familiar place |
| Managing daily tasks independently | New help needed with money, medicines, or meals |
Alzheimer’s disease and symptoms
In Alzheimer’s disease, biological changes associated with amyloid and tau gradually impair nerve-cell function. Memory loss is not the only possible presentation; language, planning, spatial awareness, judgment, or behavior may change. No single symptom makes the diagnosis. Assessment begins with the person’s and family’s history, everyday function, neurological examination, cognitive testing, and tests for reversible contributors. MRI, cerebrospinal-fluid tests, or PET may be added when clinically appropriate.
What can blood biomarkers tell us?
Blood measurements involving p-tau and amyloid are rapidly developing diagnostic aids. Some tests have regulatory clearance to help assess amyloid pathology in defined adults who already have cognitive symptoms. They are not intended to screen people without symptoms or diagnose Alzheimer’s on their own. False-positive, false-negative, and indeterminate results occur. Results must be interpreted with history, examination, and sometimes confirmatory tests. Availability and authorized use in Türkiye need separate confirmation.
Modifiable risks
Risk reduction does not guarantee that dementia will be prevented. Managing blood pressure, diabetes, cholesterol, smoking, physical inactivity, harmful alcohol use, hearing and vision loss, depression, and social isolation can still support overall and brain health. Suitable activity, balanced nutrition, fall prevention, and hearing devices should be individualized with the care team. Hobbies and social contact may be helpful, but ‘cognitive reserve’ does not guarantee a fixed delay in symptoms.
- Monitor blood pressure and metabolic risks.
- Assess hearing, vision, mood, and sleep problems.
- Support social contact and activities the person finds meaningful.
- Review medicines that may affect cognition with a clinician.
Sleep, safety, and family support
Brain fluid and waste-processing systems during sleep remain an active research area. Evidence does not justify saying that poor sleep directly damages the brain or that a particular routine clears Alzheimer proteins. Snoring, pauses in breathing, excessive daytime sleepiness, and persistent insomnia deserve assessment. After diagnosis, discuss medicine safety, cooking and driving, wandering risk, finances, future care preferences, and caregiver wellbeing early and respectfully.
References
- Dementia (opens in a new tab) — World Health Organization
- FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease (opens in a new tab) — U.S. Food and Drug Administration